US EditionPublished • loading... • Updated
Lauxera Capital Pushes Organox Towards a Record Acquisition in Medtech
Summary by L'AGEFI
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
By transferring the British company to the Japanese industrial Terumo for a value of $1.5 billion, the Parisian manager signs a record first release.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
